Impact of daratumumab/bortezomib/thalidomide and dexamethasone induction therapy on chemo-free stem cell mobilization in transplant eligible newly diagnosed multiple myeloma: a multicentre real-world experience.
Impact of daratumumab/bortezomib/thalidomide and dexamethasone induction therapy on chemo-free stem cell mobilization in transplant eligible newly diagnosed multiple myeloma: a multicentre real-world experience.
Emilia Gigliotta, Cristina Rotolo, Cirino Botta, Luca Castagna et al.
Journal
Haematologica
Topics
Multiple Myeloma Research and Treatments
article
Impact of daratumumab/bortezomib/thalidomide and dexamethasone induction therapy on chemo-free stem cell mobilization in transplant eligible newly diagnosed multiple myeloma: a multicentre real-world experience.
Emilia Gigliotta, Cristina Rotolo, Cirino Botta, Luca Castagna, Anna Marfia, Gianfranco Butera, Marika Porrazzo, Clotilde Cangialosi, C Della Costanza, Fabrizio Accardi, Alessandra Santoro, Giuseppe Sapienza, Tiziana Moscato, Caterina Patti, Stefania Tringali, Sergio Siragusa, Massimo Vincenzo Martino, Roberto Bono, Laura Noto, Andrea Rizzuto, Manuela Giuseppa Ingrascè